<p>欧洲股市经历了积极的一周，泛欧 STOXX 欧洲 600 指数上涨了 3.00%，这得益于对中东局势缓和的希望。在这种谨慎乐观的背景下，为投资者提供了探索市场中较少人知晓的细分领域（如便士股票）的有趣机会。尽管便士股票通常与较小或较新的公司相关联，但在强大的财务和基本面支持下，它们可以在较低的价格点上提供独特的增长潜力。</p>
<p>以下是筛选器中的一些选择。</p>
<h2>Kerlink (ENXTPA:ALKLK)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Kerlink SA 提供物联网（IoT）市场的网络基础设施解决方案，覆盖包括欧洲、中东、非洲、亚太地区和美洲在内的多个地区，市值为 939 万欧元。</p>
<p><strong>运营：</strong> 该公司的收入细分未披露。</p>
<p><strong>市值：</strong> 939 万欧元</p>
<p>Kerlink SA 的市值为 939 万欧元，预计 2025 年销售额为 1468 万欧元，较前一年的 1167 万欧元有所增长，同时将净亏损从 377 万欧元减少至 203 万欧元。尽管公司处于亏损状态，且负债与股本比率高达 534.4%，但 Kerlink 的短期资产超过其短期和长期负债，提供了一定的财务稳定性。由于自由现金流的增长，公司拥有超过三年的正现金流，但面临高股价波动和-99.95% 的负股本回报率。</p>
<ul>
<li>解锁我们对 Kerlink 股票分析的全面见解，请查看此财务健康报告。</li>
<li>通过访问我们的盈利增长报告来评估 Kerlink 的前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0745f05a-1ac7-49a0-9b7a-f0bb8ec6b7a5/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0745f05a-1ac7-49a0-9b7a-f0bb8ec6b7a5/chart/debt-equity-history-analysis"/></p>
<p>截至 2026 年 5 月 ENXTPA:ALKLK 的债务与股本历史及分析</p>
<h2>Aramis Group SAS (ENXTPA:ARAMI)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Aramis Group SAS 在法国、比利时、英国、奥地利、意大利和西班牙在线销售二手车辆，市值为 2.554 亿欧元。</p>
<p><strong>运营：</strong> 公司的收入主要来自翻新汽车（14.8 亿欧元），其次是预注册汽车（5.5604 亿欧元）、B2B（1.4132 亿欧元）和服务（1.2509 亿欧元）。</p>
<p><strong>市值：</strong> 2.554 亿欧元</p>
<p>Aramis Group SAS 的市值为 2.554 亿欧元，在线销售二手车辆在欧洲运营，财务表现参差不齐。尽管其短期资产覆盖负债稳定，且净负债与股本比率为 19.3%，但公司在 2026 年上半年净收入大幅下降至 6.5 万欧元，较前一年的 639 万欧元大幅下滑，受到 560 万欧元一次性损失的影响。该集团在五个国家的品牌战略统一旨在增强市场存在感和运营效率，通过翻新车辆销售支持可持续出行。</p>
<ul>
<li>点击此处访问我们完整的财务健康分析报告，以了解 Aramis Group SAS 的动态。</li>
<li>通过我们的详细增长报告评估 Aramis Group SAS 的未来盈利预期。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/1f69cde6-e300-44e9-9284-60592f266416/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/1f69cde6-e300-44e9-9284-60592f266416/chart/debt-equity-history-analysis"/></p>
<p>截至 2026 年 5 月 ENXTPA:ARAMI 的债务与股本历史及分析</p>
<h2>Biohit Oyj (HLSE:BIOBV)</h2>
<p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
<p><strong>概述：</strong> Biohit Oyj 是一家生物技术公司，生产和分销乙醛结合产品、诊断工具和系统，服务于全球的研究机构、医疗保健和工业，市值为 3877 万欧元。</p>
<p><strong>运营：</strong> 公司的收入主要来自其诊断试剂盒和设备部门，产生了 1573 万欧元的收入。</p>
<p><strong>市值：</strong> 3877 万欧元</p>
<p>Biohit Oyj 的市值为 3877 万欧元，在生物技术领域显示出良好的增长潜力。该公司最近因其 GastroPanel 测试而受到关注，该测试在智利显著减少了内窥镜检查的等待名单，减少了 87%，突显了其改善全球医疗效率的潜力。财务稳定，无负债，短期资产超过负债，Biohit 在过去一年中盈利增长 6.6%，超过行业平均水平，尽管低于其五年趋势。尽管每周波动较大，且股本回报率较低为 18.3%，Biohit 的交易价格仍大幅低于估计的公允价值。</p>
<ul>
<li>点击此处查看完整的健康分析报告，以深入了解 Biohit Oyj。</li>
<li>在此了解 Biohit Oyj 的未来增长轨迹。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/33911800-36e9-42cf-8bfa-b0adacb76fbd/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/33911800-36e9-42cf-8bfa-b0adacb76fbd/chart/financial-position-analysis"/></p>
<p>截至 2026 年 5 月 HLSE:BIOBV 的财务状况分析</p>
<h2>利用机会</h2>
<ul>
<li>在此浏览 295 只欧洲便士股票的完整清单。</li>
<li>对其他可能性感兴趣？探索 28 家领先下一代技术革命的量子计算公司，推动量子算法、超导量子比特和前沿研究的突破。</li>
</ul>
<p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
<p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>并且是免费的。</strong></p>
<p>• 连接无限数量的投资组合，并以一种货币查看总额</p>
<p>• 通过电子邮件或手机接收新的警示信号或风险提醒</p>
<p>• 跟踪您股票的公允价值</p>
<p>免费试用演示投资组合</p>

<p>欧洲股市的 STOXX Europe 600 指数上涨了 3.00%，这得益于对中东局势缓和的乐观情绪。投资者被鼓励关注一些低价股，包括 Kerlink、Aramis Group 和 Biohit Oyj，这些公司尽管财务状况各异，但都展现出独特的增长潜力。Kerlink 报告销售额为 1468 万欧元，但仍处于亏损状态；而 Aramis 由于一次性损失导致净收入下降。Biohit Oyj 在生物技术领域展现出良好的增长潜力，且没有债务，市值为 3877 万欧元</p>

<p>The European stock markets have experienced a positive week, with the pan-European STOXX Europe 600 Index climbing by 3.00% amid hopes for de-escalation in the Middle East. This backdrop of cautious optimism presents an intriguing opportunity for investors to explore lesser-known segments of the market, such as penny stocks. While traditionally associated with smaller or newer companies, penny stocks can offer unique growth potential at lower price points when supported by strong financials and fundamentals.</p>
<div class="lb-trans"><p>欧洲股市经历了积极的一周，泛欧 STOXX 欧洲 600 指数上涨了 3.00%，这得益于对中东局势缓和的希望。在这种谨慎乐观的背景下，为投资者提供了探索市场中较少人知晓的细分领域（如便士股票）的有趣机会。尽管便士股票通常与较小或较新的公司相关联，但在强大的财务和基本面支持下，它们可以在较低的价格点上提供独特的增长潜力。</p>
</div><p>Here's a peek at a few of the choices from the screener.</p>
<div class="lb-trans"><p>以下是筛选器中的一些选择。</p>
</div><h2>Kerlink (ENXTPA:ALKLK)</h2>
<div class="lb-trans"><h2>Kerlink (ENXTPA:ALKLK)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Kerlink SA offers network infrastructure solutions for the Internet of Things (IoT) market across various regions including Europe, the Middle East, Africa, the Asia-Pacific, and the Americas, with a market cap of €9.39 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Kerlink SA 提供物联网（IoT）市场的网络基础设施解决方案，覆盖包括欧洲、中东、非洲、亚太地区和美洲在内的多个地区，市值为 939 万欧元。</p>
</div><p><strong>Operations:</strong> Revenue segments for the company are not reported.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司的收入细分未披露。</p>
</div><p><strong>Market Cap:</strong> €9.39M</p>
<div class="lb-trans"><p><strong>市值：</strong> 939 万欧元</p>
</div><p>Kerlink SA, with a market cap of €9.39 million, reported sales of €14.68 million for 2025, up from €11.67 million the previous year, while reducing its net loss to €2.03 million from €3.77 million. Despite being unprofitable and having a high debt-to-equity ratio of 534.4%, Kerlink's short-term assets exceed both its short and long-term liabilities, providing some financial stability. The company has a positive cash runway exceeding three years due to growing free cash flow but faces high share price volatility and negative return on equity at -99.95%.</p>
<div class="lb-trans"><p>Kerlink SA 的市值为 939 万欧元，预计 2025 年销售额为 1468 万欧元，较前一年的 1167 万欧元有所增长，同时将净亏损从 377 万欧元减少至 203 万欧元。尽管公司处于亏损状态，且负债与股本比率高达 534.4%，但 Kerlink 的短期资产超过其短期和长期负债，提供了一定的财务稳定性。由于自由现金流的增长，公司拥有超过三年的正现金流，但面临高股价波动和-99.95% 的负股本回报率。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Kerlink stock in this financial health report.</li>
<li>Evaluate Kerlink's prospects by accessing our earnings growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁我们对 Kerlink 股票分析的全面见解，请查看此财务健康报告。</li>
<li>通过访问我们的盈利增长报告来评估 Kerlink 的前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0745f05a-1ac7-49a0-9b7a-f0bb8ec6b7a5/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/0745f05a-1ac7-49a0-9b7a-f0bb8ec6b7a5/chart/debt-equity-history-analysis"/></p>
<p>ENXTPA:ALKLK Debt to Equity History and Analysis as at May 2026</p>
<div class="lb-trans"><p>截至 2026 年 5 月 ENXTPA:ALKLK 的债务与股本历史及分析</p>
</div><h2>Aramis Group SAS (ENXTPA:ARAMI)</h2>
<div class="lb-trans"><h2>Aramis Group SAS (ENXTPA:ARAMI)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Aramis Group SAS operates in the online sale of used vehicles across France, Belgium, the United Kingdom, Austria, Italy, and Spain with a market cap of €255.40 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Aramis Group SAS 在法国、比利时、英国、奥地利、意大利和西班牙在线销售二手车辆，市值为 2.554 亿欧元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from Refurbished Cars (€1.48 billion), followed by Pre-Registered Cars (€556.04 million), B2B (€141.32 million), and Services (€125.09 million).</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自翻新汽车（14.8 亿欧元），其次是预注册汽车（5.5604 亿欧元）、B2B（1.4132 亿欧元）和服务（1.2509 亿欧元）。</p>
</div><p><strong>Market Cap:</strong> €255.4M</p>
<div class="lb-trans"><p><strong>市值：</strong> 2.554 亿欧元</p>
</div><p>Aramis Group SAS, with a market cap of €255.40 million, operates in the online sale of used vehicles across Europe and has shown mixed financial performance. Despite its stable short-term asset coverage over liabilities and satisfactory net debt to equity ratio of 19.3%, the company experienced a significant drop in net income to €0.065 million for H1 2026 from €6.39 million the previous year, impacted by a large one-off loss of €5.6 million. The group's strategic brand unification across five countries aims to enhance its market presence and operational efficiency, supporting sustainable mobility through refurbished vehicle sales.</p>
<div class="lb-trans"><p>Aramis Group SAS 的市值为 2.554 亿欧元，在线销售二手车辆在欧洲运营，财务表现参差不齐。尽管其短期资产覆盖负债稳定，且净负债与股本比率为 19.3%，但公司在 2026 年上半年净收入大幅下降至 6.5 万欧元，较前一年的 639 万欧元大幅下滑，受到 560 万欧元一次性损失的影响。该集团在五个国家的品牌战略统一旨在增强市场存在感和运营效率，通过翻新车辆销售支持可持续出行。</p>
</div><ul>
<li>Click here and access our complete financial health analysis report to understand the dynamics of Aramis Group SAS.</li>
<li>Assess Aramis Group SAS' future earnings estimates with our detailed growth reports.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击此处访问我们完整的财务健康分析报告，以了解 Aramis Group SAS 的动态。</li>
<li>通过我们的详细增长报告评估 Aramis Group SAS 的未来盈利预期。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/1f69cde6-e300-44e9-9284-60592f266416/chart/debt-equity-history-analysis" alt="" original-src="https://images.simplywall.st/company/1f69cde6-e300-44e9-9284-60592f266416/chart/debt-equity-history-analysis"/></p>
<p>ENXTPA:ARAMI Debt to Equity History and Analysis as at May 2026</p>
<div class="lb-trans"><p>截至 2026 年 5 月 ENXTPA:ARAMI 的债务与股本历史及分析</p>
</div><h2>Biohit Oyj (HLSE:BIOBV)</h2>
<div class="lb-trans"><h2>Biohit Oyj (HLSE:BIOBV)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★★</p>
<div class="lb-trans"><p><strong>Simply Wall St 财务健康评级：</strong> ★★★★★★</p>
</div><p><strong>Overview:</strong> Biohit Oyj is a biotechnology company that produces and distributes acetaldehyde-binding products, diagnostic tools, and systems for research institutions, healthcare, and industry globally, with a market cap of €38.77 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Biohit Oyj 是一家生物技术公司，生产和分销乙醛结合产品、诊断工具和系统，服务于全球的研究机构、医疗保健和工业，市值为 3877 万欧元。</p>
</div><p><strong>Operations:</strong> The company's revenue primarily comes from its Diagnostic Kits and Equipment segment, which generated €15.73 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 公司的收入主要来自其诊断试剂盒和设备部门，产生了 1573 万欧元的收入。</p>
</div><p><strong>Market Cap:</strong> €38.77M</p>
<div class="lb-trans"><p><strong>市值：</strong> 3877 万欧元</p>
</div><p>Biohit Oyj, with a market cap of €38.77 million, has shown promising growth in the biotechnology sector. The company recently gained attention with its GastroPanel test, which significantly reduced endoscopy waiting lists by 87% in Chile, underscoring its potential to improve healthcare efficiency globally. Financially stable with no debt and short-term assets exceeding liabilities, Biohit has grown earnings by 6.6% over the past year—outpacing industry averages—though this is below its five-year trend. Despite high weekly volatility and a low return on equity of 18.3%, Biohit trades at a substantial discount to estimated fair value.</p>
<div class="lb-trans"><p>Biohit Oyj 的市值为 3877 万欧元，在生物技术领域显示出良好的增长潜力。该公司最近因其 GastroPanel 测试而受到关注，该测试在智利显著减少了内窥镜检查的等待名单，减少了 87%，突显了其改善全球医疗效率的潜力。财务稳定，无负债，短期资产超过负债，Biohit 在过去一年中盈利增长 6.6%，超过行业平均水平，尽管低于其五年趋势。尽管每周波动较大，且股本回报率较低为 18.3%，Biohit 的交易价格仍大幅低于估计的公允价值。</p>
</div><ul>
<li>Jump into the full analysis health report here for a deeper understanding of Biohit Oyj.</li>
<li>Learn about Biohit Oyj's future growth trajectory here.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击此处查看完整的健康分析报告，以深入了解 Biohit Oyj。</li>
<li>在此了解 Biohit Oyj 的未来增长轨迹。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/33911800-36e9-42cf-8bfa-b0adacb76fbd/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/33911800-36e9-42cf-8bfa-b0adacb76fbd/chart/financial-position-analysis"/></p>
<p>HLSE:BIOBV Financial Position Analysis as at May 2026</p>
<div class="lb-trans"><p>截至 2026 年 5 月 HLSE:BIOBV 的财务状况分析</p>
</div><h2>Taking Advantage</h2>
<div class="lb-trans"><h2>利用机会</h2>
</div><ul>
<li>Navigate through the entire inventory of 295 European Penny Stocks here.</li>
<li>Interested In Other Possibilities? Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.</li>
</ul>
<div class="lb-trans"><ul>
<li>在此浏览 295 只欧洲便士股票的完整清单。</li>
<li>对其他可能性感兴趣？探索 28 家领先下一代技术革命的量子计算公司，推动量子算法、超导量子比特和前沿研究的突破。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>本文由 Simply Wall St 撰写，内容具有一般性。<strong>我们基于历史数据和分析师预测提供评论，仅使用无偏见的方法，我们的文章不构成财务建议。</strong> 这并不构成买入或卖出任何股票的推荐，也未考虑您的目标或财务状况。我们旨在为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><h3><strong>New:</strong> Manage All Your Stock Portfolios in One Place</h3>
<div class="lb-trans"><h3><strong>新功能：</strong> 在一个地方管理您的所有股票投资组合</h3>
</div><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p>
<div class="lb-trans"><p>我们为股票投资者创建了 <strong>终极投资组合助手</strong>，<strong>并且是免费的。</strong></p>
</div><p>• Connect an unlimited number of Portfolios and see your total in one currency</p>
<div class="lb-trans"><p>• 连接无限数量的投资组合，并以一种货币查看总额</p>
</div><p>• Be alerted to new Warning Signs or Risks via email or mobile</p>
<div class="lb-trans"><p>• 通过电子邮件或手机接收新的警示信号或风险提醒</p>
</div><p>• Track the Fair Value of your stocks</p>
<div class="lb-trans"><p>• 跟踪您股票的公允价值</p>
</div><p>Try a Demo Portfolio for Free</p>
<div class="lb-trans"><p>免费试用演示投资组合</p>
</div>

2026 年 5 月值得关注的欧洲低价股